Sumitomo Pharma America To Unveil New Data at ASH Meeting
03 Nov 2025 //
PR NEWSWIRE
Sumitomo, NCI Partner to Advance Enzomenib Cancer Study
14 Apr 2025 //
PR NEWSWIRE
Sumitomo Pharma Presents Data on Nuvisertib and Enzomenib at ASH
09 Dec 2024 //
PR NEWSWIRE

Market Place
Sourcing Support